Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Acq. announced
Director departure
|
|
TETRALOGIC PHARMACEUTICALS Corp (TLOG)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 11/16/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 11/14/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 11/14/2016 |
4
| NOMURA SECURITIES INTERNATIONAL, INC. (See Remarks) has filed a Form 4 on TETRALOGIC PHARMACEUTICALS CORP|
Txns:
| Disposed of convertible notes
@ $0
Acquired 892,850 options to buy
@ $0
Acquired convertible notes
@ $0 |
|
| 11/14/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 11/14/2016 |
4
| GEODE CAPITAL MANAGEMENT LP (See Remarks) has filed a Form 4 on TETRALOGIC PHARMACEUTICALS CORP|
Txns:
| Disposed of options to buy
@ $0
Acquired 1,257,144 options to buy
@ $0
Acquired options to buy
@ $0 |
|
| 11/14/2016 |
4
| TELEMETRY SECURITIES, L.L.C. (See Remarks) has filed a Form 4 on TETRALOGIC PHARMACEUTICALS CORP|
Txns:
| Disposed of options to buy
@ $0
Acquired 838,094 options to buy
@ $0
Acquired options to buy
@ $0 |
|
| 11/14/2016 |
4
| LINDEN ADVISORS LP (See Remarks) has filed a Form 4 on TETRALOGIC PHARMACEUTICALS CORP|
Txns:
| Disposed of options to buy
@ $0
Acquired 2,095,239 options to buy
@ $0
Acquired options to buy
@ $0 |
|
| 11/14/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 11/14/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/10/2016 |
4
| Clarus Lifesciences II, L.P. (10% Owner) has filed a Form 4 on TETRALOGIC PHARMACEUTICALS CORP|
Txns:
| Sold 103,123 shares
@ $0.19, valued at
$19.6k
Sold 230,507 shares
@ $0.16, valued at
$36.9k
|
|
| 02/05/2016 |
4
| Clarus Lifesciences II, L.P. (10% Owner) has filed a Form 4 on TETRALOGIC PHARMACEUTICALS CORP|
Txns:
| Sold 82,583 shares
@ $0.15, valued at
$12.4k
Sold 500,026 shares
@ $0.14, valued at
$70k
Sold 832,881 shares
@ $0.2, valued at
$166.6k
|
|
| 02/02/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/28/2016 |
4
| Clarus Lifesciences II, L.P. (10% Owner) has filed a Form 4 on TETRALOGIC PHARMACEUTICALS CORP|
Txns:
| Sold 69,425 shares
@ $0.3, valued at
$20.8k
Sold 209,984 shares
@ $0.27, valued at
$56.7k
Sold 32,521 shares
@ $0.26, valued at
$8.5k
|
|
| 07/14/2015 |
4
| Pecora Andrew L (Director) has filed a Form 4 on TETRALOGIC PHARMACEUTICALS CORP |
| 07/13/2015 |
4
| Pecora Andrew L (Director) has filed a Form 4 on TETRALOGIC PHARMACEUTICALS CORP |
| 07/06/2015 |
4
| Schmitt Paul J (Director) has filed a Form 4 on TETRALOGIC PHARMACEUTICALS CORP|
Txns:
| Bought 3,500 shares
@ $2.334, valued at
$8.2k
Bought 6,500 shares
@ $2.3366, valued at
$15.2k
|
|
| 03/31/2015 |
4
| Meyers Pete A. (CFO & Treasurer) has filed a Form 4 on TETRALOGIC PHARMACEUTICALS CORP|
Txns:
| Bought 5,000 shares
@ $4.35, valued at
$21.8k
|
|
| 03/30/2015 |
4
| BUCHI J KEVIN (President & CEO) has filed a Form 4 on TETRALOGIC PHARMACEUTICALS CORP|
Txns:
| Bought 5,000 shares
@ $4.2295, valued at
$21.1k
|
|
| 01/30/2015 |
4
| Sherman Richard L. (See Remarks) has filed a Form 4 on TETRALOGIC PHARMACEUTICALS CORP|
Txns:
| Granted 100,000 options
@ $5.25, valued at
$525k
Granted 75,000 restricted stock units
@ $0 |
|
| 01/30/2015 |
4
| Woody James N. (Director) has filed a Form 4 on TETRALOGIC PHARMACEUTICALS CORP |
| 01/30/2015 |
4
| Schmitt Paul J (Director) has filed a Form 4 on TETRALOGIC PHARMACEUTICALS CORP|
Txns:
| Granted 10,000 options
@ $5.25, valued at
$52.5k
Granted 10,000 options
@ $5.25, valued at
$52.5k
|
|
| 01/30/2015 |
4
| STEINMETZ MICHAEL (Director) has filed a Form 4 on TETRALOGIC PHARMACEUTICALS CORP|
Txns:
| Granted 10,000 options
@ $5.25, valued at
$52.5k
|
|
| 01/30/2015 |
4
| Reed Douglas MD (Director) has filed a Form 4 on TETRALOGIC PHARMACEUTICALS CORP|
Txns:
| Granted 10,000 options
@ $5.25, valued at
$52.5k
|
|
| 01/30/2015 |
4
| KISHBAUCH MICHAEL D (Director) has filed a Form 4 on TETRALOGIC PHARMACEUTICALS CORP|
Txns:
| Granted 10,000 options
@ $5.25, valued at
$52.5k
|
|
| 01/30/2015 |
4
| GRAY MARY ANN (Director) has filed a Form 4 on TETRALOGIC PHARMACEUTICALS CORP|
Txns:
| Granted 10,000 options
@ $5.25, valued at
$52.5k
|
|
| 01/30/2015 |
4
| Russell Lesley (COO) has filed a Form 4 on TETRALOGIC PHARMACEUTICALS CORP|
Txns:
| Granted 100,000 options
@ $5.25, valued at
$525k
Granted 75,000 restricted stock units
@ $0 |
|
| 01/30/2015 |
4
| Pecora Andrew L (Director) has filed a Form 4 on TETRALOGIC PHARMACEUTICALS CORP |
| 01/30/2015 |
4
| Meyers Pete A. (CFO & Treasurer) has filed a Form 4 on TETRALOGIC PHARMACEUTICALS CORP|
Txns:
| Granted 100,000 options
@ $5.25, valued at
$525k
Granted 75,000 restricted stock units
@ $0 |
|
| 01/30/2015 |
4
| BUCHI J KEVIN (President & CEO) has filed a Form 4 on TETRALOGIC PHARMACEUTICALS CORP|
Txns:
| Granted 200,000 options
@ $5.25, valued at
$1.1M
Granted 150,000 restricted stock units
@ $0 |
|
| 01/30/2015 |
4
| Begley Colin Glenn (Chief Scientific Officer & SVP) has filed a Form 4 on TETRALOGIC PHARMACEUTICALS CORP|
Txns:
| Granted 100,000 options
@ $5.25, valued at
$525k
Granted 75,000 restricted stock units
@ $0 |
|
| 01/29/2015 |
4
| ONSI DOUGLAS E (Director) has filed a Form 4 on TETRALOGIC PHARMACEUTICALS CORP|
Txns:
| Granted 10,000 options to buy
@ $5.25, valued at
$52.5k
|
|
| 01/09/2015 |
4
| BUCHI J KEVIN (President & CEO) has filed a Form 4 on TETRALOGIC PHARMACEUTICALS CORP|
Txns:
| Bought 5,000 shares
@ $5.0362, valued at
$25.2k
|
|
| 12/12/2014 |
4
| Begley Colin Glenn (Chief Scientific Officer & SVP) has filed a Form 4 on TETRALOGIC PHARMACEUTICALS CORP|
Txns:
| Bought 5,900 shares
@ $6.16, valued at
$36.3k
|
|
| 12/11/2014 |
4
| BUCHI J KEVIN (President & CEO) has filed a Form 4 on TETRALOGIC PHARMACEUTICALS CORP|
Txns:
| Bought 5,000 shares
@ $6.012, valued at
$30.1k
|
|
|
|
|